This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Immunization  • Pediatrics, Other  • Alert me on articles by topic

Arch Pediatr Adolesc Med. 2004;158:311.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

For some vaccines, parents and physicians in private offices have a choice of products (eg, hepatitis B vaccine) produced by different manufacturers. Occasionally, choice extends from the private marketplace to the public side of vaccine provision; some states allow health care providers choice of manufacturer for the federal Vaccines for Children program (VFC)-purchased or other government-financed vaccines, whereas other states do not. Because all vaccines licensed for use in the United States have passed Food and Drug Administration tests of safety and efficacy, the choice of vaccine brand made by parents, physicians, or government purchasers is based on a variety of other factors, including price, availability, combinations with other vaccines, minor variations in immunogenicity, and personal relationships with manufacturer representatives. Absent from this decision process has been any assessment of variation in the pain associated with the injection of one vaccine product for a specific antigen(s) relative to another.

The . . . [Full Text of this Article]

Gary L. Freed, MD, MPH
Division of General Pediatrics
University of Michigan
300 N Ingalls 6E08
Ann Arbor
MI 48109-0456

RELATED ARTICLE

Effect of Choice of Measles-Mumps-Rubella Vaccine on Immediate Vaccination Pain in Infants
Moshe Ipp, Eyal Cohen, Morton Goldbach, and Colin Macarthur
Arch Pediatr Adolesc Med. 2004;158(4):323-326.
ABSTRACT | FULL TEXT